Medicine and Dentistry
Infection
100%
Intensive Care
100%
Retrospective Cohort Study
100%
Piperacillin/Tazobactam
100%
Carbapenem Derivative
100%
Intensive Care Unit
50%
Post-Hoc Analysis
20%
Randomized Clinical Trial
10%
Septic Shock
10%
Glucocorticoid
10%
Antibiotic Therapy
10%
Antiinfective Agent
10%
Broad-Spectrum Antibiotic
10%
Keyphrases
Retrospective Cohort Study
100%
Carbapenems
100%
Intensive Care
100%
Piperacillin-tazobactam
100%
DIANA
40%
Intensive Care Unit
20%
Critically Ill Patients
20%
Intensive Care Unit Patients
10%
Randomized Clinical Trial
10%
Drug Dependence
10%
Antibiotic Treatment
10%
Length of Hospital Stay
10%
Septic Shock
10%
Glucocorticoid Therapy
10%
Broad-spectrum Antibiotics
10%
Initial Antibiotics
10%
Intensive Care Unit Care
10%
Clinical Cure
10%
Intensive Care Unit Length of Stay
10%
Antimicrobial De-escalation
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Carbapenem Derivative
100%
Infection
100%
Piperacillin Plus Tazobactam
100%
Randomized Clinical Trial
10%
Antiinfective Agent
10%
Antibiotics
10%
Glucocorticoid
10%
Antibiotic Agent
10%
Septic Shock
10%